Interpreter mediated cognitive assessments – stakeholder experiences informing guidelines and training DVD and use of video conferencing software
Social justice and equity of access to care can be compromised by the communication gaps which frequently occur during interpreter-assisted cognitive assessments. There is a shortage of interpreters in many languages, even in metropolitan areas, and difficulties for people to access services with appropriate interpreters.
Randomised , double-blind, parallel- group, placebo-controlled, fixed-dose study of Lu AE58054 in patients with moderate Alzheimer’s Disease treated with Donepezil
This project was to assess change from baseline in the ADAS-Cog. This is a phase 2 study. It included participants with a diagnosis of Alzheimer’s disease and who have been on Donepezil (Aricept) for 4 months, stable for 3 months
A Phase 3 Multicenter, Randomised, Placeb-Controlled, Double Blind Twelve month Safety and Efficacy study Evaluating Dimebon in Patients with Mild-Moderate Alzheimer’s Disease on Donepezil
To see whether Dimebon given orally will slow the decline of AD compared to placebo as measured using the Alzheimer’s disease Assessment Scale- Cogniive subscore (ADAS-Cog) and Alzheimer’s Disease Cooperative Study- Activities of Daily Living (ADCS-ADL). To evaluate the safety and tolerability of Dimebon at two doses: 20mg or 5 mg orally.
The effect of Gamma Secretase inhibition on the progression of Alzheimer’s Disease: Ly450139 versus placebo
To see whether Ly450139 given orally will slow the decline of AD compared to placebo as measured using the Alzheimer’s disease Assessment Scale- Cogniive subscore (ADAS-Cog) and Alzheimer’s Disease Cooperative Study- Activities of Daily Living (ADCS-ADL).
The Assessment of Older People with dementia and depression of Culturally and Linguistically Diverse Backgrounds: A review of current practice and the development of guidelines for Victorian Aged Care Assessment Services
This project sought to improve assessment practice of Aged Care Assessment Services (ACAS) for CALD clients in relation to dementia and depression. A key step was to identify available instruments and determine suitability in the ACAS setting.